Theopista Lotto | Health Professions | Best Research Article Award

Posted on by Book of Award

Ms. Theopista Lotto | Health Professions | Best Research Article Award

Ifakara Health Institute | Tanzania

Author Profile

Orcid

🎓 Early Academic Pursuits

Ms. Theopista Lotto embarked on her academic journey with a deep commitment to healthcare and research. She earned her Bachelor of Pharmacy from Muhimbili University, Dar es Salaam, Tanzania (2003-2007), laying a strong foundation in pharmaceutical sciences. Her passion for healthcare monitoring and evaluation led her to pursue an MSc in Health Monitoring and Evaluation at Mzumbe University, Morogoro, Tanzania (2013-2015). Further advancing her expertise, she attained a PhD in Epidemiology and Public Health from Swiss TPH, Switzerland (2021-2023), equipping her with cutting-edge skills in public health research and antimicrobial resistance (AMR) studies.

💼 Professional Endeavors

Ms. Lotto has demonstrated exceptional leadership and expertise in public health, antimicrobial stewardship, and pharmaceutical research through her extensive professional journey. She currently serves as an M&E Advisor for the CDC Project on Sustainable Health System Strengthening at Mzumbe University (2024-Present), where she designs and implements evaluation frameworks and supports national health initiatives. Her role as a Technical Expert and In-Country Consultant for the Commonwealth Pharmacist Association (2023-Present) underscores her influence in antimicrobial stewardship, ensuring that healthcare programs align with Tanzania’s National Action Plan on AMR. Previously, she was a Research Scientist at Ifakara Health Institute (2020-2024), where she led multiple AMR surveillance projects and cross-sectional studies on antimicrobial use. Her earlier career includes impactful roles such as M&E Advisor at Tanzania Institute of Monitoring and Evaluation (2019-2020), DHIS2 Coordinator at Mbeya District Council (2015-2019), and District Pharmacist at Mbeya District Council (2009-2015). These positions highlight her extensive experience in data-driven decision-making, pharmaceutical logistics, and healthcare policy implementation.

🔬 Contributions and Research Focus

Ms. Lotto’s research focuses on antimicrobial resistance, antimicrobial stewardship, public health surveillance, and health system strengthening. She has played a pivotal role in:

  • Designing and leading AMU & AMS projects at Ifakara Health Institute, conducting large-scale community surveys to assess antimicrobial use in Tanzania.
  • Implementing electronic Clinical Decision Support Algorithms (CDSA) to promote antibiotic stewardship and improve pediatric healthcare outcomes.
  • Enhancing health monitoring systems through her expertise in Health Information Systems (DHIS2) and supporting national stakeholders with data-driven decision-making.

Her research has significantly contributed to the development of antimicrobial resistance policies, ensuring that Tanzania aligns with global AMR mitigation strategies.

🏆 Accolades and Recognition

Ms. Lotto’s contributions have earned her recognition as a leading researcher in public health and pharmacy. She has been instrumental in multiple government and international health projects, showcasing her ability to foster cross-sector collaborations with organizations like the CDC, Commonwealth Pharmacist Association, and Ifakara Health Institute. Her technical expertise in antimicrobial stewardship has positioned her as a sought-after consultant in Tanzania’s healthcare system.

🌍 Impact and Influence

Ms. Lotto’s work has had a far-reaching impact on Tanzania’s public health landscape. She has:

  • Strengthened AMR surveillance and antimicrobial stewardship programs at a national level.
  • Improved healthcare monitoring and evaluation frameworks through innovative data collection and analysis.
  • Supported policy formulation and implementation, working closely with government ministries and international health bodies.
  • Provided training and mentorship to healthcare professionals, ensuring sustainable knowledge transfer in pharmaceutical management and public health research.

Her influence extends beyond research; she actively engages policymakers, healthcare practitioners, and academic institutions to drive meaningful change in the fight against AMR.

🔮 Legacy and Future Contributions

As a visionary leader in public health and pharmacy, Ms. Lotto continues to pave the way for stronger healthcare systems in Tanzania. Her future contributions are expected to focus on:

  • Expanding AMR research to include more comprehensive national and regional studies.
  • Developing innovative pharmaceutical management tools to optimize drug distribution and usage.
  • Strengthening international collaborations to combat antimicrobial resistance on a global scale.
  • Training and mentoring the next generation of researchers in epidemiology and public health.

With her unwavering dedication and expertise, Ms. Lotto is set to leave a lasting legacy in global health research and pharmaceutical sciences, ensuring sustainable and evidence-based healthcare practices for generations to come.

 

Publications

📄 Population-Based Prevalence of Antibiotic Residuals in Low, Moderate and High Malaria Endemicity Areas in Tanzania
Author(s): Theopista Lotto, Joanna Gallay, Martin Zuakulu, Beatrice Ternon, Laurent Arthur Decosterd, Alexandra V. Kulinkina, Blaise Genton
Journal: Antibiotics
Year: 2025

Simeon Ikechukwu Egba | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Posted on by Book of Award

Dr. Simeon Ikechukwu Egba | Biochemistry, Genetics and Molecular Biology | Editorial Board Member

Kampala International University | Uganda

Author Profile

Scopus

Orcid

Early Academic Pursuits 📚

Dr. Simeon Ikechukwu Egba’s academic journey began with his foundational education in Nigeria. After completing his secondary education at Community Secondary School, Eha-ohuala and Special Science School, Igbeagu, he pursued his undergraduate studies at the University of Nigeria, Nsukka, where he earned a Bachelor’s degree in Biochemistry in 2000. His academic curiosity and dedication to biochemistry led him to continue his studies at the same institution, earning a Master's degree in 2010 and later a Ph.D. in Biochemistry in 2014. His commitment to furthering his expertise in medical laboratory sciences was also demonstrated through studies at Nnamdi Azikiwe University Teaching Hospital-Nnewi.

Professional Endeavors 🏫

Dr. Egba's professional journey in academia spans over twelve years, during which he has held numerous positions that showcase his leadership and commitment to research and education. He has served as a lecturer in Biochemistry at various institutions, including Michael Okpara University of Agriculture, Umudike, and currently at Kampala International University, Uganda. His responsibilities have included teaching courses in biochemistry, overseeing laboratory sessions, and coordinating various academic functions such as the Student Industrial Work Experience Scheme (SIWES). Additionally, he has taken on key administrative roles, including being a member of the University Senate, and has led projects in research and curriculum development.

Contributions and Research Focus 🔬

Dr. Egba’s research interests are diverse and impactful, focusing on medical biochemistry, natural products, immune-modulation, endocrinology, and biochemical toxicology. His research has not only expanded the scientific understanding of these fields but has also contributed to real-world applications, such as exploring the immune-modulatory effects of herbal extracts and investigating glucose transport enhancement. He has made significant contributions to diabetes research, with several studies on anti-diabetic poly-herbal formulas. His scholarly work includes over 70 publications and successful supervision of 18 postgraduate students, many of whom have gone on to have successful academic careers.

Accolades and Recognition 🏅

Dr. Egba's academic excellence has earned him recognition within the scientific community. He has received multiple research grants, including those from the TETFUND, for projects that focus on diabetes and immunological responses. His dedication to his field is evident not only in his numerous publications but also in his role as a mentor, guiding over 150 undergraduate students through their research projects, many of whom have received scholarships to pursue postgraduate studies worldwide. Dr. Egba is an active member of the Nigerian Society of Biochemistry and Molecular Biology (NSBMB) and the Association of Medical Laboratory Scientists of Nigeria (AMLSN).

Impact and Influence 🌍

Dr. Egba’s impact extends beyond academia through his direct contributions to research and the development of future scholars. His research on the biochemical effects of natural products has influenced studies on immune-modulation and endocrinology, providing valuable insights into how natural compounds can influence human health. He has also played a pivotal role in improving the quality of laboratory practices and biochemistry education. His students, both undergraduate and postgraduate, continue to carry forward his legacy in research and academia, furthering his influence globally.

Legacy and Future Contributions 🌟

Dr. Egba’s future contributions are poised to further cement his legacy as a leading academic and researcher. His ongoing research projects aim to continue advancing the understanding of the biochemical pathways in diseases such as diabetes, and his work with poly-herbal formulations could have significant therapeutic implications. As he trains the next generation of biochemists and medical laboratory scientists, Dr. Egba’s influence will continue to shape the future of research and medical science, particularly in the fields of immunology and endocrinology.

Publication

  • 📜 Effects of exposure to volatile organic compounds (VOCs) content from paint on automobile paint workers in Nsukka, South Eastern Nigeria
    Authors: Ogbodo, J.O., Egba, S.I., Ogbodo, C.G., Onwurah, I.E., Njoku, O.U.
    Journal: Heliyon
    Year: 2024
  • 📜 Understanding apoptosis in sickle cell anemia patients: Mechanisms and implications
    Authors: Obeagu, E.I., Ubosi, N.I., Obeagu, G.U., Egba, S.I., Bluth, M.H.
    Journal: Medicine (United States)
    Year: 2024
  • 📜 Evaluation of fertility hormones and biochemical stress initiated by toxicant in diet prepared with fish smoked with polyethylene (plastic) materials as a fuel source
    Authors: Uhuo, E.N., Egba, S.I., Alaebo, P.O., Obike, C.A., Ede, I.S.
    Journal: Comparative Clinical Pathology
    Year: 2023
  • 📜 Antioxidative properties of Adansonia digitata L. (baobab) leaf extract exert protective effect on doxorubicin-induced cardiac toxicity in Wistar rats
    Authors: Uhuo, E.N., Egba, S.I., Nwuke, P.C., Obike, C.A., Kelechi, G.K.
    Journal: Clinical Nutrition Open Science
    Year: 2022
  • 📜 Renoprotective effects of Adansonia digitata leaf extract on renal function and histopathological changes in vancomycin-induced nephrotoxicity in Wistar rats
    Authors: Uhuo, E.N., Egba, S.I., Nwuke, P.N., Odinamadu, H.
    Journal: Comparative Clinical Pathology
    Year: 2022

 

Jillian Perry | Materials Science | Best Researcher Award

Posted on by Book of Award

Assist Prof Dr. Jillian Perry | Materials Science | Best Researcher Award

University of North Carolina - Chapel Hill | United States

Author Profile

Google Scholar

🧠 Early Academic Pursuits

Assist. Prof. Dr. Jillian Perry's academic journey began with a Bachelor of Science in Chemical Engineering, awarded Cum Laude from the University of Florida in 2004, with a minor in Chemistry. Building on her solid foundation, she pursued a PhD in Biomedical Engineering at the same university, where she conducted pioneering research on chitosan nanotube synthesis for drug delivery applications. Her dissertation, supervised by Dr. John D. Steward and Dr. Charles R. Martin, laid the groundwork for a career focused on innovative solutions in drug delivery and nanotechnology.

💼 Professional Endeavors

Currently an Assistant Professor at the University of North Carolina’s Eshelman School of Pharmacy, Dr. Perry also contributes to the Center for Nanotechnology in Drug Delivery. Since joining UNC in 2010 as a Postdoctoral Research Associate at the Lineberger Comprehensive Cancer Center, she has been mentored by renowned researchers like Dr. Joseph M. DeSimone. Over the years, she progressed from a Research Associate Scientist to her current position, collaborating on high-impact research in pharmacoengineering and molecular pharmaceutics.

🧬 Contributions and Research Focus

Dr. Perry’s research explores 3D-printed microneedles, transdermal drug delivery systems, and nanoparticle-based cancer immunotherapies. She has authored numerous impactful publications, contributing extensively to fields such as tumor targeting and transdermal vaccination techniques. Her work includes significant studies on hydrogel-based cancer treatments and PRINT nanoparticle technology for enhanced therapeutic delivery.

🏆 Accolades and Recognition

Dr. Perry has been honored with several awards, such as the 2020 Junior Faculty Development Award and the NanoDDS Poster Award in 2018. Her 3D-printed vaccine patch technology received global attention and won the Fast Company’s World Changing Ideas Award in 2022. She was also recognized for her academic excellence with prestigious scholarships like the University Scholars Scholarship and Bright Futures Scholarship during her undergraduate years.

🌍 Impact and Influence

With an H-index of 19 and over 2,130 citations, Dr. Perry’s research has influenced the scientific community's understanding of nanomedicine and drug delivery technologies. Her innovative approaches in microneedle design and 3D printing for vaccine delivery have potential applications beyond academia, transforming practical healthcare delivery methods and advancing public health initiatives worldwide.

📜 Legacy and Future Contributions

As a thought leader in nanotechnology and biopharmaceuticals, Dr. Perry is expected to continue making groundbreaking contributions to transdermal vaccine development and targeted cancer therapies. Her active role in patenting novel drug delivery systems and designing biocompatible materials solidifies her legacy as a researcher committed to pioneering health solutions. Future contributions will likely include further advancements in non-invasive drug delivery and enhanced treatment efficacy in challenging medical fields, paving the way for transformative healthcare solutions.

 

Publications

📄  Development of 3D printed microneedles of varied needle geometries and lengths, designed to improve dermal delivery of topically applied psoriasis treatments

Authors: Pünnel LC, Palmtag M, Lunter DJ, Perry JL
Journal: European Journal of Pharmaceutics and Biopharmaceutics
Year: 2024

📄  3D-printed Lattice Microneedle Array Patches for Tunable and Versatile Intradermal Delivery

Authors: Rajesh NU, Hwang J, Xu Y, Saccone MA, Hung A, Hernandez RAS, Coates IA, Driskill MM, Dulay MT, Jacobson GB, Tian S, Perry JL#, DeSimone JM
Journal: Advanced Materials
 Year: 2024

📄  Development of a biocompatible 3D hydrogel scaffold using CLIP for the delivery of cell therapy to treat recurrent glioblastoma

Authors: Kass L, Morrent T, Zhang Y, DeVane C, Logan J, Tessema A, Perry JL#, Hingtgen SD
 Journal: Bioengineering and Translational Medicine
Year: 2024

📄  3D-Printed Microarray Patches for Transdermal Applications

Authors: Rajesh NU, Coates I, Driskill MM, Dulay MT, Hsiao K, Ilyn D, Jacobson GB, Kwak JW, Lawrence M, Perry JL, Shea CO, Tian SM, DeSimone JM
 Journal: JACS Au
 Year: 2022

📄  Transdermal Vaccination via 3D Printed Microneedles Induces Potent Humoral and Cellular Immunity

Authors: Caudill CL, Perry JL, Illiadis K, Tessema AT, Lee BJ, Mecham BS, Tian S, DeSimone JM
Journal: PNAS
 Year: 2021

 

Govindaraj Sabarees | Materials Science | Best Researcher Award

Posted on by Book of Award

Dr. Govindaraj Sabarees | Materials Science | Best Researcher Award

Shri Venkateshwara College of Pharmacy | India

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Dr. Govindaraj Sabarees began his academic journey with a solid foundation in pharmacy. He earned his B. Pharmacy degree from Sankaralingam Bhuvaneshwari College of Pharmacy, Sivakasi, Tamil Nadu, achieving first-class honors. This was followed by an M. Pharmacy in Pharmaceutical Chemistry from C.L. Baid Metha College of Pharmacy, Chennai, where he also graduated with first-class distinction. His academic achievements laid the groundwork for his research-oriented career.

Professional Endeavors 🏢

Dr. Sabarees gained significant experience as a Bioanalytical Research Associate at Amaris Clinical, a division of Caplin Point Laboratories, Chennai. During this period, he honed his skills in bioanalytical methods, high-end equipment handling, and synthetic organic chemistry. His hands-on experience in these areas has contributed to his expertise in pharmaceutical research, particularly in the development and validation of analytical methods.

Contributions and Research Focus 🔬

Dr. Sabarees has made substantial contributions to pharmaceutical research, particularly in the field of wound healing and molecular docking. His research includes the discovery of curcumin analogs as potential wound healing agents and the development of novel electrospun nanofibers for biomedical applications. His work has been widely published in reputable journals, showcasing his ability to bridge the gap between theoretical research and practical applications in medicine.

Accolades and Recognition 🏆

Throughout his career, Dr. Sabarees has received recognition for his contributions to pharmaceutical research. His participation in various national and international conferences, where he has presented his findings, has earned him a respected place in the academic and research community. His publications in high-impact journals further underscore his commitment to advancing the field of pharmaceutical sciences.

Impact and Influence 🌍

Dr. Sabarees's research has had a significant impact on the development of new therapeutic agents and materials, particularly in the area of wound management. His work on molecular docking and dynamics simulations has opened new avenues for drug discovery and development. His influence extends to his role as a mentor and educator, where he has guided junior researchers and pharmacy students, helping shape the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

As Dr. Sabarees continues to advance in his career, his ongoing research and future projects promise to make lasting contributions to the field of pharmaceutical sciences. His work on electrospun nanofibers and molecular docking is likely to lead to new breakthroughs in drug delivery systems and therapeutic materials. Dr. Sabarees's legacy will be one of innovation, dedication, and a commitment to improving healthcare outcomes through cutting-edge research.

 

Publications

  • 📖 Fabrication of Quercetin-Functionalized Morpholine and Pyridine Motifs-Laden Silk Fibroin Nanofibers for Effective Wound Healing in Preclinical Study
    Authors: Govindaraj Sabarees, Vadivel Velmurugan, Siddan Gouthaman, Viswas Raja Solomon, Subramani Kandhasamy
    Journal: Pharmaceutics
    Year: 2024
  • 📖 Advances in Electrospun Chitosan Nanofiber Biomaterials for Biomedical Applications
    Authors: Ganesan Padmini Tamilarasi, Manikandan Krishnan, Govindaraj Sabarees, S. Gouthaman, Alagarsamy Veerchamy, Viswas Raja Solomon
    Journal: Materials Advances
    Year: 2023
  • 📖 Discovery of new naphthyridine hybrids against enoyl-ACP reductase (inhA) protein target of Mycobacterium tuberculosis: Molecular docking, molecular dynamics simulations studies
    Authors: Govindaraj Sabarees, Vadivel Velmurugan, Viswas Raja Solomon
    Journal: Chemical Physics Impact
    Year: 2023
  • 📖 Recent Trends in Electrospun Antibacterial Nanofibers for Chronic Wound Management
    Authors: Ganesan Padmini Tamilarasi, Govindaraj Sabarees, Krishnan Manikandan, Siddan Gouthaman, Veerachamy Alagarsamy, Viswas Raja Solomon
    Journal: Current Nanomedicine
    Year: 2023
  • 📖Recent Developments in Electrospun Nanofibers as Delivery of Phytoconstituents for Wound Healing
    Authors: Govindaraj Ajith, Ganesan Padmini Tamilarasi, Govindaraj Sabarees, Siddan Gouthaman, Krishnan Manikandan, Vadivel Velmurugan, Veerachamy Alagarsamy, Viswas Raja Solomon
    Journal: Drugs and Drug Candidates
    Year: 2023

 

Ahmet Özdemir | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Posted on by Book of Award

Prof Dr. Ahmet Özdemir | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Anadolu University | Turkey

Author Profile

Scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Ahmet Özdemir's academic journey began at Salihli Cumhuriyet Elementary School (1978-1983), followed by Salihli 50. Yıl Secondary School (1983-1986) and Salihli High School (1986-1989). His passion for pharmacy led him to Anadolu University Faculty of Pharmacy, where he completed his undergraduate studies (1990-1994). He pursued further education at the Graduate School of Health Sciences, Department of Pharmaceutical Chemistry at Anadolu University, earning a Master's degree (1995-1996) and a Doctor's degree (1996-2004).

Professional Endeavors 💼

Prof. Dr. Özdemir's professional career commenced at Anadolu University as a Research Assistant (1997-2004). He progressed to Research Assistant Doctor (2004-2005), Lecturer (2005-2007), and Assistant Professor Doctor (2007-2010). His dedication and expertise earned him the title of Associate Professor Doctor (2010-2015), and he has been serving as a Professor Doctor since 2015.

Contributions and Research Focus 🔍

Prof. Dr. Özdemir's research is marked by significant contributions to pharmaceutical chemistry. His Master's thesis focused on "The studies on the synthesis, structure elucidations and determination of physicochemical parameters of some 2-substituted-1H-phenantro[9,10-d]imidazole compounds," under the supervision of Prof. Dr. İlhan Işıkdağ. His PhD thesis, supervised by Prof. Dr. Gülhan Turan, investigated the "Synthesis of some 1-[(N,N-disubstituted-thiocarbonylthio)acetyl]-3-(2-thienyl)-5-aryl-2-pyrazoline derivatives and their antifungal, antibacterial activities."

Accolades and Recognition 🏅

Prof. Dr. Özdemir's work has been widely recognized, earning him numerous awards:

  • Anadolu University Article Performance Award (2014, 2016, 2017, 2018, 2020)
  • Anadolu University Gold Article Performance Award (2015)
  • Anadolu University Platinum Article Performance Award (2015)
  • Anadolu University Academic Success Award (2019)
  • ISIF'21 Silver Medal for the invention "Targeted Novel Triazolothiadiazine Derivatives for The Treatment of Lung Cancer" (2021)

Impact and Influence 🌟

Prof. Dr. Özdemir's impact extends beyond research. He has held key administrative roles, including Associate Director of Anadolu University Yunus Emre Vocational School (2011-2014) and Vice Academic Director of the Anadolu University Open Education Faculty, Department of Health Administration (2015-present). His mentorship has guided many students, as evidenced by his supervision of numerous master’s and doctoral dissertations.

Legacy and Future Contributions 🚀

Prof. Dr. Özdemir’s legacy is built on his unwavering commitment to advancing pharmaceutical chemistry. His innovative research, administrative leadership, and dedication to education have left an indelible mark on Anadolu University and the broader scientific community. As he continues his work, Prof. Dr. Özdemir is poised to make further groundbreaking contributions that will shape the future of pharmaceutical sciences.

 

Publications

📜Title: Design, Synthesis, and Biological Evaluation of a New Series of Imidazothiazole-Hydrazone Hybrids as Dual EGFR and Akt Inhibitors for NSCLC Therapy
Authors: Mehlika Dilek Altıntop, İpek Ertorun, Gülşen Akalın Çiftçi, Ahmet Özdemir
Journal: European Journal of Medicinal Chemistry
Year: 2024

📜Title: Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents
Authors: Baramaki, I., Altıntop, M.D., Arslan, R., Hasan, A., Bektaş Türkmen, N.
Journal: ACS Omega
Year: 2024

📜Title: Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents
Authors: Altıntop, M.D., Cantürk, Z., Özdemir, A.
Journal: ACS Omega
Year: 2023

📜Title: Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy
Authors: Erdönmez, B., Altıntop, M.D., Akalın Çiftçi, G., Özdemir, A., Ece, A.
Journal: ACS Omega
Year: 2023

📜Title: A New Series of Hydrazones as Small-Molecule Aldose Reductase Inhibitors
Authors: Altıntop, M.D., Demir, Y., Türkeş, C., Beydemir, Ş., Özdemir, A.
Journal: Archiv der Pharmazie
Year: 2023

📜Title: A New Series of Thiazole-Hydrazone Hybrids for Akt-Targeted Therapy of Non-Small Cell Lung Cancer
Authors: Orujova, T., Ece, A., Akalın Çiftçi, G., Özdemir, A., Altıntop, M.D.
Journal: Drug Development Research
Year: 2023

Assoc Prof Dr. Nicola Micale | Pharmacology, Toxicology and Pharmaceutical Science | Best Research Award

Posted on by Book of Award

Assoc Prof Dr. Nicola Micale | Pharmacology, Toxicology and Pharmaceutical Science | Best Research Award

University of Messina | Italy

 Author Profile

Scopus

Early Academic Pursuits

Associate Professor Dr. Nicola Micale commenced his academic journey with an exceptional focus on Chemistry and Pharmaceutical Technology, culminating in an honored degree from the University of Messina. This foundation laid the groundwork for his specialization in pharmacology and pharmaceutical sciences.

Professional Endeavors

Micale's career trajectory has been marked by a series of esteemed positions, from pivotal research roles to impactful lectureships across Europe. His academic pursuits have extended globally, emphasizing collaborative research ventures and immersive academic experiences.

Contributions and Research Focus

Central to Micale's contributions is his intensive focus on neurodegenerative disorders and innovative drug design. His research spans diverse areas, ranging from peptidomimetics to targeted drug development, showcasing a commitment to combatting microbial infections and malignancies.

Accolades and Recognition

Micale's exemplary research earned him notable recognition, including the Farmindustria Award for Pharmaceutical Research and invitations to deliver lectures at prestigious international conferences. These accolades affirm his expertise and contributions to the field.

Impact and Influence

Beyond his research contributions, Micale's influence is evident through his pivotal roles on the editorial boards of multiple international scientific journals. His role as a reviewer for esteemed publications underscores his commitment to shaping scholarly dialogue and validating scientific research.

Legacy and Future Contributions

Associate Professor Dr. Nicola Micale's legacy is rooted in his multidisciplinary approach to pharmaceutical sciences and his dedication to fostering global scientific collaborations. His ongoing contributions are poised to drive advancements in pharmaceutical research, leaving a lasting imprint on the field's progression and innovation.

Notable Publications

Synthesis of SARS-CoV-2 Mpro inhibitors bearing a cinnamic ester warhead with in vitro activity against human coronaviruses 2023 (6)

Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 M pro 2023 (5)

Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M pro Inhibitors 2023 (3)